treatments could face delays of up to a year.
In environmental protection, an inquiry by the UK Environmental Audit Committee published in January estimates that up to one-third of EU legislation will be difficult to transpose into UK law. And those protections -for wildlife, habitats and biodiversity -that can be transferred through the Great Repeal Bill will then be detached from underpinning sources of expert advice, no longer updated, with no UK body to enforce them.
Over time, the United Kingdom can build up new advisory and regulatory capacity. But this won't be quick or easy. And there are a handful of areas in which the reliance on EU-wide structures is especially acute.
The nuclear research community was particularly alarmed by January's unexpected announcement that Brexit would also require UK withdrawal from the European Atomic Energy Community (Euratom). Among Euratom's responsibilities are nuclear safety standards and non-proliferation. Through its supply agency, it also oversees the market for medical radioisotopes. Many scientists are now calling for the Euratom exit to be decoupled from the Brexit timetable, because its functions simply can't be replaced by 2019, as mandated by Article 50. A further issue is ensuring that UK policymakers have access to the best available evidence and advice to support Article 50 negotiations. Here there have been calls from the House of Commons Science and Technology Committee for the new Brexit departments to appoint chief scientific advisers. Ministers have said only that they are considering this.
It is particularly important for the new Department for International Trade to draw scientific advice into negotiations, to underpin consumer protection and environmental standards -and to avoid any hint of a UK race to the regulatory bottom in pursuit of new markets, as advocated by the more gung-ho supporters of Brexit.
These changes can, of course, cut both ways. Regulatory gaps may become an opportunity to cut red tape. Forced withdrawal from EU expert networks might create domestic opportunities for some. In optimistic moments, some scientific leaders suggest the United Kingdom could become a test bed for more flexible approaches to new technologies and treatments. But for now, these questions sit a long way down the list of issues that must be resolved in 24 months. And attention to them is patchy, under-resourced and paralysed by high politics. WORLD VIEWA personal take on events
